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Endothelial dysfunction is widely considered as a prognostic marker of future cardiovascular events in clinical settings, even in patients who do not have untoward symptoms of cardiovascular disease. 1 Thus, treatments aimed at restoring endothelial dysfunction have important implications Many studies have demonstrated that supplementary treatments can improve endothelial function. 2 These favourable effects may be due to improved abnormal nitric oxide metabolism, mediated by mechanisms such as antioxidant or anti-inflammatory effects. Isoflavones are contained in soy and are mainly phytooestrogens, which are chemically similar in structure to physiological oestrogens. It has been demonstrated that isoflavones can lower blood pressure and serum lipid levels, as well as function as antioxidant and anti-inflammatory agents in both laboratory and clinical settings. 3 It is therefore apparent that treatment with isoflavones could ameliorate endothelial dysfunction. However, the effect of isoflavone supplements on endothelial function remains controversial.
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The results of several studies regarding the effect of isoflavone supplementation on endothelial function, as determined by assessing brachial flow-mediated dilatation (FMD), are summarized in Table 1 . Because of the oestrogen-like nature of isoflavones, the subjects in many of these studies were menopausal women. It has been demonstrated that endothelial dysfunction often develops in women after the menopause 2 and that FMD values can range from 'severely reduced' to 'normal' in these subjects. 4 -13 Therefore, it is not surprising that isoflavones had no effect on the endothelial function in subjects with normal FMD readings (.8.0%). 5, 6, 12, 13 On the other hand, isoflavone supplementation improved endothelial function in subjects with a reduced FMD (,6.0%), 4, 7, 11, 12 15 This study therefore raised two important points that must be emphasized. First, this is the first study to confirm the effect of isoflavones on endothelial function in patients with established atherosclerosis in a randomized, double-blind, placebo-controlled trial. Secondly, this study demonstrated that the improved FMD measurements inversely correlated with baseline FMD levels with isoflavone treatment, indicating that isoflavones could restore endothelial function in patients with severe endothelial dysfunction. These findings imply that future clinical trials of isoflavone supplementation should be conducted mainly in patients with endothelial dysfunction. In this report, the isoflavone-induced change in FMD values was only 1.2%. However, measurements of brachial artery diameter and increased brachial blood flow after hyperaemia did not change with treatment. Furthermore, although this was a parallel-group design study, the number of subjects was sufficient to detect a small FMD change.
2 Therefore, the small but significant change in the observed FMD values has important implications. Despite these promising findings, future studies that examine the While their measurements of oxidative stress would be more complete if the urinary excretion of 8-isoprostane and 8-hydroxy-2'-deoxyguanosine had been measured, it is admirable that they endeavoured to examine the anti-inflammatory effect of isoflavones in patients with ischaemic stroke. Many studies have demonstrated the close relationship between inflammation and endothelial dysfunction, and the anti-inflammatory effects of isoflavones may be one mechanism responsible for restoring endothelial function in these cases.
In conclusion, Chan et al. 15 demonstrated the effect of oral isoflavone supplements on the endothelial function in patients with ischaemic stroke in a randomized, double-blind, placebocontrolled trial. This effect may be more pronounced in patients with severe endothelial dysfunction, and further clinical studies using isoflavone supplements should be conducted in such patients. In addition, based on the findings of Chan et al., 15 it is anticipated that a large study will show that isoflavone supplementation has a positive influence on endothelial function in patients with DM.
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